Introduction {#s1}
============

Avian coccidiosis is one of the most costly infectious diseases affecting the commercial poultry industry [@pone.0059786-Shirley1]. Coccidia that infect chickens include *Eimeria acervulina*, *E. tenella*, *E. maxima*, *E. brunetti*, *E. necatrix*, *E. praecox*, and *E. mitis*. These apicomplexan protists invade cells of the intestinal epithelium, evoking necrotic tissue destruction and resulting in reduced body weight gain in broilers, decreased egg production in layers, and fecal shedding of viable parasites that re-infect susceptible animals upon ingestion. Over the preceding 40 years, avian coccidiosis has been mainly controlled by prophylactic chemotherapeutic drugs. More recently, the use of coccidia vaccines has reduced the need for in-feed medication [@pone.0059786-Allen1]. Because host immunity to *Eimeria* infection is species-specific, currently available live, attenuated vaccines consist of mixtures of four or more *Eimeria* species. The basis of using live coccidia vaccines involves a continuous excretion/re-ingestion cycle of an initial low dose of parasites, which progressively induces protective flock immunity. However, live vaccines often lead to an early reduction in weight gain and may not be effective against regional antigenic variants absent from the formulation. Therefore, novel approaches are needed to more effectively control coccidiosis in commercial poultry flocks.

Vaccine delivery in conjunction with an adjuvant offers one means to increase potency. By definition, an adjuvant is an agent that stimulates the immune system and increases the host response to an antigen without itself conferring a specific antigenic effect [@pone.0059786-Bowersock1]. Some adjuvants act by sequestering antigens in physically restricted areas, termed depots, to provide an extended time period of antigenic stimulation. This depot effect is essential for the efficacy of the majority of human and veterinary vaccine adjuvants, particularly with vaccines consisting of pathogen subunits (proteins, nucleic acids, and carbohydrates). Currently, aluminum hydroxide (alum) is only adjuvant approved for human use in the U.S. and Canada. Other adjuvants have been licensed for human use in Europe, including the water-in-oil (W/O) emulsions, MF59 and AS03, and the TLR4 agonist, monophosphoryl lipid A in alum [@pone.0059786-DeGregorio1]. A larger list of adjuvants is available for veterinary use [@pone.0059786-Heegaard1].

The Montanide ISA series of adjuvants include the W/O emulsions, Montanide™ ISA 70 VG (ISA 70) and Montanide™ ISA 71 VG (ISA 71). Both formulations are mineral oil-based solutions incorporating a highly refined mannitol/oleic acid emulsifier [@pone.0059786-Aucouturier1]. ISA 71 is similar to ISA 70 except that it contains an improved mineral oil enabling the preferential stimulation of Th1-type cell-mediated immunity. ISA 70 and ISA 71 have been successfully applied to enhance immune response against pathogens of poultry, cattle, and small ruminants [@pone.0059786-Dupuis1]. Our previous studies demonstrated that either ISA 70 or ISA 71 in conjunction with the *Eimeria* recombinant protein, profilin, was associated with enhanced protective immunity against experimental avian coccidiosis, as measured by increased body weight gain and/or decreased fecal oocyst shedding compared with profilin alone [@pone.0059786-Jang1], [@pone.0059786-Jang2], [@pone.0059786-Jang3]. However, the specific effects were dependent upon the particular adjuvant used, the species of infecting *Eimeria*, and the parameter of infection measured. Profilin/ISA 70 and profilin/ISA 71 increased post-infection weight gains, but only following *E. acervulina* infection, whereas profilin/ISA 71, but not profilin/ISA 70, decreased parasite shedding following infection with *E. acervulina* or *E. tenella*. In addition, we have demonstrated the utility of comparative microarray hybridization for identifying global transcriptional responses to various vaccination strategies that correlate with protection against experimental *Eimeria* infection [@pone.0059786-Kim1], [@pone.0059786-Kim2], [@pone.0059786-Kim3]. Therefore, the current study was undertaken to compare the dynamics of lymphocyte transcriptome responses in chickens immunized with profilin/ISA 70 *vs*. profilin alone, or with profilin/ISA 71 *vs*. profilin alone, and to use this information to identify the better adjuvant with the potential for stimulating protective immunity against experimental avian coccidiosis.

Materials and Methods {#s2}
=====================

Recombinant Profilin Protein and Adjuvants {#s2a}
------------------------------------------

Recombinant profilin, originally derived from *E. acervulina*, was expressed in *Escherichia coli* with a maltose binding protein epitope tag and purified by amylase affinity chromatography as described [@pone.0059786-Jang1]. Purified profilin was emulsified with ISA 70 or ISA 71 at a 30∶70 ratio (w:w, profilin:adjuvant) as recommended by the manufacturer (Seppic, Puteaux, France).

Chickens and Profilin Immunization {#s2b}
----------------------------------

One-day-old Ross broiler chickens (Longenecker's Hatchery, Elizabethtown, PA) were housed in Petersime starter brooder units and provided with feed and water *ad libitum*. At 7 days post-hatch, chickens were subcutaneously immunized with 50 μg of profilin emulsified in ISA 70 or ISA 71. Control chickens were immunized with PBS plus adjuvant, or with profilin in the absence of adjuvant. At 7 days post-primary immunization, the chickens were transferred to hanging cages (2 birds per cage) and given secondary subcutaneous booster injections identical with the primary immunization. All experiments were approved by the Beltsville Agricultural Research Center Small Animal Care and Use Committee.

Total RNA Preparation and Labeling {#s2c}
----------------------------------

At 7 days post-secondary immunization, birds were sacrificed, single spleen cell suspensions were prepared, and lymphocytes were isolated by Percoll density gradient centrifugation as described [@pone.0059786-Min1]. Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA) and pooled into 2 equal aliquots (3 birds/sample). RNAs were amplified using the Two-Color Quick Amp Labeling Kit (Agilent Technologies, Santa Clara, CA) with cyanine 3 (Cy3)- or Cy5-labeled CTP. Labeled RNAs were purified using the RNeasy Mini Kit (Qiagen, Valencia, CA) and quantified with a Nanodrop ND-1000 UV-VIS spectrophotometer (Thermo Fisher Scientific, Waltham, MA).

Microarray Experimental Design {#s2d}
------------------------------

A standard reference design with hybridization of Cy3- and Cy5-labeled RNAs [@pone.0059786-Mcshane1] was used to compare mRNA transcript levels in chickens immunized with profilin/ISA 70 *vs*. profilin alone and profilin/ISA 71 *vs*. profilin alone. Two biological replicates were conducted in each comparison with substitution of Cy3- and Cy5-labeled RNAs to prevent data distortion from sample labeling as previously described [@pone.0059786-Kim2]. Labeled RNAs were hybridized to a Chicken Gene Expression Microarray (Agilent Technologies, Santa Clara, CA) containing 43,803 elements using the Gene Expression Hybridization Kit (Agilent Technologies) with constant mixing at 10 rpm for 17 hr at 65°C. After washing, microarray images were scanned, and data extraction and analysis were performed using Feature Extraction software version 10.7.3.1 (Agilent Technologies).

Microarray Data Analysis {#s2e}
------------------------

GeneSpring GX10 software (Silicon Genetics, Redwood, CA) was used to qualify and normalize hybridization images, and to perform fold-change analyses as described [@pone.0059786-Kim1], [@pone.0059786-Kim2]. Median signal intensities were qualified by subtracting the median local background and normalized by locally-weighted scatterplot smoothing (LOWESS). Flag information was applied to strain the spots with 100% valid values from each group and one-way analysis of variance (ANOVA) was performed to analyze the significance of differences between treatment groups. To generate signal ratios, signal channel values from the profilin/ISA 70 and profilin/ISA 71 groups were divided by the channel values from the profilin-only group. Modulated mRNA transcripts, defined as those with a cutoff of *P*\<0.0005, were applied by asymptotic T-test analysis. The significantly differentially expressed transcripts were filtered using the Volcano Plot method [@pone.0059786-Jin1] built by comparison among the various immunization groups. All microarray information and data was deposited online into the Gene Expression Omnibus (GEO) server (accession number GES 40743).

Bioinformatic Analysis {#s2f}
----------------------

Differentially expressed transcripts were analyzed by Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, CA). Each identifier was mapped to its corresponding gene object in the Ingenuity Knowledge Base. Both up-regulated and down-regulated identifiers were defined as value parameters for the analysis. These focus genes were overlaid onto a global molecular network developed from information contained in the Ingenuity Knowledge Base. Biological functional analysis was performed and the canonical pathways from the datasets were mapped with the Ingenuity Pathways Knowledge Base. The Fischer's exact test was used to calculate the probability that each biological function and associated pathways assigned to that dataset was statistically significant.

Experimental Eimeria Infection {#s2g}
------------------------------

At 7 days post-secondary immunization, chickens were uninfected or were orally infected with 1.0×10^4^ sporulated oocysts of *E. acervulina, E. tenella* or *E. maxima* as described [@pone.0059786-Song1]. The coccidia parasites were originally isolated and maintained at the Animal and Natural Resources Institute, U.S. Department of Agriculture (Beltsville, MD). Prior to infection, sporulated oocysts were cleaned by floatation on 2.5% sodium hypochlorite, washed three times with PBS, and enumerated using a hemocytometer.

Body Weight Gains and Fecal Oocyst Shedding {#s2h}
-------------------------------------------

Body weights of uninfected and *Eimeria*-infected chickens (8/group) were measured at 0 and 10 days post-infection. For determination of fecal oocysts numbers, birds (8/group) were placed on wire oocyst collection cages, fecal samples were collected between 6 and 10 days post-infection, and total oocysts were enumerated using a McMaster counting chamber as described [@pone.0059786-Ding1].

Anti-profilin Serum Antibody Levels {#s2i}
-----------------------------------

At 3 days post-infection, chickens (5/group) were euthanized by cervical dislocation, blood was collected by cardiac puncture, and sera were prepared by low speed centrifugation. Serum antibodies against profilin were measured by enzyme-linked immunosorbent assay (ELISA) as described [@pone.0059786-Jang3], [@pone.0059786-Ding1]. Ninety-six-well microtiter plates were coated overnight with 10 μg/well of purified recombinant profilin, washed with PBS containing 0.05% Tween 20, and blocked with PBS containing 1% BSA. Serum samples were added and incubated for 1 hr with continuous shaking, the plates were washed, and bound antibody was detected with peroxidase-conjugated rabbit anti-chicken IgG secondary antibody and peroxidase-substrate (Sigma, St. Louis, MO). Optical density (OD) values at 450 nm were measured with an automated microplate reader (Bio-Rad, Richmond, CA).

Intestinal Cytokine mRNA Levels {#s2j}
-------------------------------

At 3 day post-infection, chickens (3/group) were euthanized by cervical dislocation and the intestinal duodenum (*E. acervulina*-infected), jejunum (*E. tenella*-infected), and cecum (*E. maxima*-infected) were removed. Tissues were incised longitudinally, gently washed with ice-cold Hank's Balanced Salt Solution (Sigma), and intraepithelial lymphocytes (IELs) were isolated by density gradient centrifugation as described [@pone.0059786-Hong1], [@pone.0059786-Hong2]. Total RNA was isolated, 5.0 μg were incubate with 1.0 U of DNase I and 1.0 μl of 10× DNase I reaction buffer (Sigma) for 15 min at room temperature, 1.0 μl of stop solution was added, and the mixture was heated at 70°C for 10 min. RNA was reverse-transcribed using the StrataScript first-strand synthesis system (Stratagene, La Jolla, CA) according to the manufacturer's recommendations. PCR amplification and detection were carried out using equivalent amounts of total RNA and oligonucleotide primers for IFN-γ, IL-2, IL-10, IL-17A, and the glyceraldehydes-3-phosphate dehydrogenase (GAPDH) internal control ([Table 1](#pone-0059786-t001){ref-type="table"}) with the Mx3000P system and Brilliant SYBR Green QPCR master mix (Stratagene). Standard curves were generated using log~10~ diluted standard RNAs and the levels of individual transcripts were normalized to those of GAPDH by the Q-gene program [@pone.0059786-Muller1]. To normalize RNA levels between samples within an experiment, the mean threshold cycle (C~t~) values for the amplification products were calculated by pooling values from all samples in that experiment. Each analysis was performed in triplicate.

10.1371/journal.pone.0059786.t001

###### Oligonucleotide primers used for quantitative RT-PCR of chicken cytokine transcripts.

![](pone.0059786.t001){#pone-0059786-t001-1}

  RNA Target          Primer Sequences         PCR Product Size (bp)   GenBank Accession No.
  ------------ ------------------------------ ----------------------- -----------------------
  IFN- γ                                                              
  Forward       5′-AGCTGACGGTGGACCTATTATT-3′            259                   Y07922
  Reverse         5′-GGCTTTGCGCTGGATTC-3′                             
  IL-2                                                                
  Forward       5′-TCTGGGACCACTGTATGCTCT-3′             256                  AF000631
  Reverse       5′-ACACCAGTGGGAAACAGTATCA-3′                          
  IL-10                                                               
  Forward         5′-CGGGAGCTGAGGGTGAA-3′               272                  AJ621614
  Reverse        5′-GTGAAGAAGCGGTGACAGC-3′                            
  IL-17A                                                              
  Forward       5′-CTCCGATCCCTTATTCTCCTC-3′             292                  AJ493595
  Reverse        5′-AAGCGGTTGTGGTCCTCAT-3′                            
  GAPDH                                                               
  Forward        5′-GGTGGTGCTAAGCGTGTTAT-3′             264                   K01458
  Reverse        5′-ACCTCTGTCATCTCTCCACA-3′                           

Statistical Analysis {#s2k}
--------------------

Body weight gains, oocyst shedding, anti-profilin antibody titers, and cytokine levels were expressed as means ± SD. Mean values of different treatment groups were compared using ANOVA or the Duncan's multiple range test with SPSS 15.0 for Windows (SPSS Inc., Chicago, IL). Differences between means were considered statistically significant at *P*\<0.05.

Results {#s3}
=======

Spleen Lymphocyte Transcript Levels Following Immunization with Profilin Plus ISA 70 or Profilin Plus ISA 71 {#s3a}
------------------------------------------------------------------------------------------------------------

Microarray hybridizations were performed using the Agilent Technology Chicken Gene Expression Microarray with total RNAs isolated from spleen lymphocytes of chickens immunized with profilin alone, profilin plus ISA 70, or profilin plus ISA 71 to identify global transcriptome changes in the respective treatment groups. A critical *P* value of 0.0005 was employed to compare transcript levels in the profilin/ISA 70 *vs*. profilin alone, the profilin/ISA 71 *vs*. profilin alone, and the profilin/ISA 70 *vs*. profilin/ISA 71 groups. From this dataset, the levels of 509 (288 up-regulated, 221 down-regulated), 296 (157 up-regulated, 139 down-regulated), and 315 (183 up-regulated, 132 down-regulated) mRNAs were identified as differentially altered in the denoted comparisons ([Figure 1A](#pone-0059786-g001){ref-type="fig"}). Twenty-two altered transcripts were identical in the profilin/ISA 70 *vs*. profilin alone (11 up-regulated, 11 down-regulated) and the profilin/ISA 71 *vs*. profilin alone (10 up-regulated, 12 down-regulated) groups ([Figure 1B](#pone-0059786-g001){ref-type="fig"}). [Tables 2](#pone-0059786-t002){ref-type="table"} and [3](#pone-0059786-t003){ref-type="table"} list the 20 most up-regulated and 20 most down-regulated transcripts for these latter two comparisons in decreasing order of fold-change.

![Comparison of the numbers of differentially altered transcript levels in spleen lymphocytes when comparing chickens immunized with profilin plus ISA 70 *vs*. profilin alone, profilin plus ISA 71 *vs*. profilin alone, or profilin plus ISA 70 *vs*. profilin plus ISA 71.\
(A) The numbers of up-regulated and down-regulated transcripts. (B) The number of identical transcripts.](pone.0059786.g001){#pone-0059786-g001}

10.1371/journal.pone.0059786.t002

###### Differential gene transcript levels comparing profilin plus ISA 70 *vs*. profilin alone.

![](pone.0059786.t002){#pone-0059786-t002-2}

  Symbol                               Entrez Gene Name                       Fold-Change[1](#nt101){ref-type="table-fn"}        Location              Function
  ---------------- --------------------------------------------------------- --------------------------------------------- --------------------- --------------------
  Up-regulated                                                                                                                                   
  UPK3BL                               Uroplakin 3B-like                                         6.744                            Unknown               Other
  C1QTNF3               C1q and tumor necrosis factor related protein 3                          5.840                      Extracellular Space         Other
  APOLD1                     Apolipoprotein L domain containing 1                                4.682                            Unknown               Other
  CHRDL1                                Chordin-like 1                                           4.044                      Extracellular Space         Other
  PIGR                         Polymeric immunoglobulin receptor                                 3.942                        Plasma Membrane        Transporter
  EPCAM                        Epithelial cell adhesion molecule                                 3.669                        Plasma Membrane           Other
  SCGN                   Secretagogin, EF-hand calcium binding protein                           3.645                           Cytoplasm              Other
  IRX4                                Iroquois homeobox 4                                        3.597                            Nucleus         Transcr. regulator
  RBM6                            RNA binding motif protein 6                                    2.857                            Nucleus               Other
  Pdlim3                             PDZ and LIM domain 3                                        2.789                        Plasma Membrane           Other
  ADPRHL1                         ADP-ribosylhydrolase like 1                                    2.687                            Unknown               Enzyme
  FMOD                                   Fibromodulin                                            2.493                      Extracellular Space         Other
  LIMA1                         LIM domain and actin binding 1                                   2.368                           Cytoplasm              Other
  Krt19                                   Keratin 19                                             2.356                           Cytoplasm              Other
  SCRN1                                   Secernin 1                                             2.347                           Cytoplasm              Other
  LMCD1                         LIM and cysteine-rich domains 1                                  2.315                           Cytoplasm        Transcr. regulator
  FAM40B                 Family with sequence similarity 40, member B                            2.311                            Unknown               Other
  ARL8A                         ADP-ribosylation factor-like 8A                                  2.274                           Cytoplasm              Enzyme
  C11orf96                    Chromosome 11 open reading frame 96                                2.221                            Unknown               Other
  STMN2                                 Stathmin-like 2                                          2.161                           Cytoplasm              Other
  Down-regulated                                                                                                                                 
  ART1                             ADP-ribosyltransferase 1                                     −18.34                        Plasma Membrane           Enzyme
  MMP7                  Matrix metallopeptidase 7 (matrilysin, uterine)                         −4.322                      Extracellular Space       Peptidase
  CRTC1                   CREB regulated transcription coactivator 1                            −3.184                            Nucleus         Transcr. regulator
  ID2               Inhibitor of DNA binding 2, DN helix-loop-helix protein                     −2.479                            Nucleus         Transcr. regulator
  ALDH9A1                 Aldehyde dehydrogenase 9 family, member A1                            −2.274                           Cytoplasm              Enzyme
  TBC1D2B                        TBC1 domain family, member 2B                                  −2.242                            Unknown               Other
  DEF6                    Differentially expressed in FDCP 6 homolog                            −2.240                      Extracellular Space         Other
  FBXO18                          F-box protein, helicase, 18                                   −2.218                            Nucleus               Other
  MT-CO2                        Cytochrome c oxidase subunit II                                 −2.116                           Cytoplasm              Enzyme
  TMEM144                          Transmembrane protein 144                                    −1.870                            Unknown               Other
  SQSTM1                                Sequestosome 1                                          −1.869                           Cytoplasm        Transcr. regulator
  VDR                   Vitamin D (1,25- dihydroxyvitamin D3) receptor                          −1.865                            Nucleus          Nuclear receptor
  IL8                                    Interleukin 8                                          −1.836                      Extracellular Space        Cytokine
  C19orf28                    Chromosome 19 open reading frame 28                               −1.796                            Unknown               Other
  ATP5B                ATP synthase, H^+^ transporting, mitochondrial, β                        −1.782                           Cytoplasm           Transporter
  RRBP1                Ribosome binding protein 1 homolog 180 kDa (dog)                         −1.733                           Cytoplasm           Transporter
  PARP4                  Poly (ADP-ribose) polymerase family, member 4                          −1.702                            Nucleus               Enzyme
  C9orf102                    Chromosome 9 open reading frame 102                               −1.701                            Unknown               Enzyme
  HYAL2                           Hyaluronoglucosaminidase 2                                    −1.696                           Cytoplasm              Enzyme
  CNOT1                    CCR4-NOT transcription complex, subunit 1                            −1.689                           Cytoplasm              Other

Values are the log~2~ of the ratio of gene transcript levels (profilin/ISA 70 ÷ profilin alone).

10.1371/journal.pone.0059786.t003

###### Differential gene transcript levels comparing profilin plus ISA 71 *vs*. profilin alone.

![](pone.0059786.t003){#pone-0059786-t003-3}

  Symbol                                Entrez Gene Name                       Fold-Change[1](#nt102){ref-type="table-fn"}        Location              Function
  ---------------- ---------------------------------------------------------- --------------------------------------------- --------------------- --------------------
  Up-regulated                                                                                                                                    
  SST                                     Somatostatin                                            6.132                      Extracellular Space         Other
  GCG                                       Glucagon                                              4.113                      Extracellular Space         Other
  CHST12                Carbohydrate (chondroitin 4) sulfotransferase 12                          2.643                           Cytoplasm              Enzyme
  LSP1                           Lymphocyte-specific protein 1                                    2.435                           Cytoplasm              Other
  F7                                 Coagulation factor VII                                       2.431                        Plasma Membrane         Peptidase
  TLX1                             T-cell leukemia homeobox 1                                     2.136                            Nucleus         Transcr. regulator
  GP9                              Glycoprotein IX (platelet)                                     2.112                        Plasma Membrane           Other
  FAM40B                  Family with sequence similarity 40, member B                            2.047                            Unknown               Other
  FDFT1                    Farnesyl-diphosphate farnesyltransferase 1                             2.031                           Cytoplasm              Enzyme
  COL17A1                           Collagen, type XVII, α 1                                      1.947                        Plasma Membrane           Other
  ARL8A                         ADP-ribosylation factor-like 8A                                   1.914                           Cytoplasm              Enzyme
  TERT                          Telomerase reverse transcriptase                                  1.893                            Nucleus               Enzyme
  PRKCH                               Protein kinase C, β                                         1.836                           Cytoplasm              Kinase
  TTC9                         Tetratricopeptide repeat domain 9                                  1.813                            Unknown               Other
  HSD11B1                    Hydroxysteroid (11-β) dehydrogenase 1                                1.805                           Cytoplasm              Enzyme
  EPSTI1                   Epithelial stromal interaction 1 (breast)                              1.792                            Unknown               Other
  IRAK1BP1            IL-1 receptor-associated kinase 1 binding protein 1                         1.758                            Unknown               Other
  TUBB1                                   Tubulin, β 1                                            1.731                           Cytoplasm              Other
  CCDC81                        Coiled-coil domain containing 81                                  1.728                            Unknown               Other
  P4HA3                    Polyl 4-hydroxylase, alpha polypeptide III                             1.691                            Unknown               Enzyme
  Down-regulated                                                                                                                                  
  RAB14                        RAB14, member RAS oncogene family                                 −5.333                           Cytoplasm              Enzyme
  SFTPA1                             Surfactant protein A1                                       −3.568                      Extracellular Space      Transporter
  USP32                         Ubiquitin specific peptidase 32                                  −2.270                           Cytoplasm              Enzyme
  PDE5A                        Posphodiesterase 5A, cGMP-specific                                −2.229                           Cytoplasm              Enzyme
  AHR                              Aryl hydrocarbon receptor                                     −2.044                            Nucleus          Nuclear receptor
  GOLGB1                                   Golgin B1                                             −1.959                           Cytoplasm              Other
  ABI3BP                  ABI family, member 3 (NESH) binding protein                            −1.953                      Extracellular Space         Other
  XPO1                          Exportin 1 (CRM1 homolog, yeast)                                 −1.774                            Nucleus            Transporter
  ATP6V0D2          ATPase, H^+^ transporting, lysosomal 38 kDa, subunit d2                      −1.766                           Cytoplasm           Transporter
  VWF                                Von Willebrand factor                                       −1.757                      Extracellular Space         Other
  PHACTR1                      Phosphatase and actin regulator 1                                 −1.724                           Cytoplasm              Other
  NUP153                              Nucleoporin 153 kDa                                        −1.720                            Nucleus            Transporter
  FAM91A1                Family with sequence similarity 91, member A1                           −1.647                            Unknown               Other
  ARID4A                   AT rich interactive domain 4A (RBP1-like)                             −1.579                            Nucleus         Transcr. regulator
  PROC              Protein C (inactivator of coagulation factors Va, VIIIa)                     −1.575                      Extracellular Space       Peptidase
  PIAS1                      Protein inhibitor of activated STAT, 1                              −1.525                            Nucleus         Transcr. regulator
  NUP155                              Nucleoporin 155 kDa                                        −1.512                            Nucleus            Transporter
  MLLT4                    Myeloid/lymphoid or mixed-lineage leukemia                            −1.506                            Nucleus               Other
  NAPG               N-ethylmaleimide-sensitive factor attachment protein,γ                      −1.506                           Cytoplasm           Transporter
  AMN1                    Antagonist of mitotic exit network 1 homolog                           −1.454                        Plasma Membrane           Other

Values are the log~2~ of the ratio of gene transcript levels (profilin/ISA 71 ÷ profilin alone).

Biological Function and Pathway Analysis of Differentially Regulated Splenocyte Transcripts {#s3b}
-------------------------------------------------------------------------------------------

The differently modified datasets were mapped to the corresponding genes of the human, mouse, and rat genomes using Ingenuity Knowledge Base software. From this analysis, 192 chicken genes were identified and annotated in the profilin/ISA 70 *vs*. profilin alone comparison, and 112 genes in the profilin/ISA 71 *vs*. profilin alone comparison. Biological function analysis using the IPA database identified the category "Disease and Disorder" as the most significantly associated with the genes identified in both comparisons, with 25 and 24 significantly associated biological functions respectively ([Table 4](#pone-0059786-t004){ref-type="table"}). Of these, two biological functions were uniquely associated with the profilin/ISA 70 *vs*. profilin alone comparison, "Endocrine System Disorders" and "Nutritional Disease", and one biofunction was exclusively associated with the profilin/ISA 71 *vs*. profilin alone comparison, "Antimicrobial Response". Finally, the IPA database was used to identify the canonical pathways associated with the respective biofunctions of the two comparison groups. Two pathways were identified in the profilin/ISA 70 *vs*. profilin alone comparison, while 10 pathways were recognized in the profilin/ISA 71 *vs*. profilin alone comparison ([Figure 2](#pone-0059786-g002){ref-type="fig"}).

![IPA canonic pathway analysis of differential transcript levels in chickens immunized with profilin plus ISA 70 *vs*. profilin alone and profilin plus ISA 71 *vs*. profilin alone.\
Illustrated are the pathways that were significantly associated with genes encoding the modulated transcripts in the comparisons of profilin plus ISA 70 *vs*. profilin alone (2 pathways) and profilin plus ISA 71 *vs*. profilin alone (10 pathways). The left ordinate and bars illustrates the statistical significance of each pathway expressed as the -log~10~ (*P* value) calculated using the right-tailed Fisher exact test. The right ordinate and line illustrate the ratio of the number of genes from the dataset that map to the indicated pathway divided by the total number of genes within that particular pathway.](pone.0059786.g002){#pone-0059786-g002}

10.1371/journal.pone.0059786.t004

###### Comparisons of biological functions in the category of "Diseases and Disorders" of the differentially expressed transcripts following vaccination with profilin plus ISA 70 *vs*. profilin alone and profilin plus ISA 71 *vs*. profilin alone.

![](pone.0059786.t004){#pone-0059786-t004-4}

  Biological Function[1](#nt103){ref-type="table-fn"}    Profilin/ISA 70 *vs*. Profilin[2](#nt104){ref-type="table-fn"}   Biological Function[1](#nt103){ref-type="table-fn"}   Profilin/ISA 71 *vs*. Profilin[2](#nt104){ref-type="table-fn"}
  ----------------------------------------------------- ---------------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------------------
  Genetic Disorder                                                              0.000114--0.0296                                           Genetic Disorder                                            0.000597--0.0283
  Reproductive System Disease                                                   0.000114--0.0229                                         Hematological Disease                                         0.000597--0.0283
  Infectious Disease                                                            0.000522--0.0239                                                Cancer                                                 0.000704--0.0265
  Inflammatory Response                                                         0.000522--0.0305                                   Organismal Injury & Abnormalities                                   0.000880--0.0265
  Hypersensitivity Response                                                     0.00154--0.0229                                        Gastrointestinal Disease                                        0.00195--0.0187
  Developmental Disorder                                                        0.00168--0.0230                                         Hepatic System Disease                                         0.00195--0.0187
  Cardiovascular Disease                                                        0.00499--0.0229                                          Neurological Disease                                          0.00290--0.0283
  Respiratory Disease                                                           0.00499--0.0229                                          Inflammatory Response                                         0.00404--0.0283
  Organismal Injury & Abnormalities                                             0.00649--0.0251                                       Connective Tissue Disorders                                      0.00457--0.0142
  Immunological Disease                                                         0.00737--0.0229                                          Inflammatory Disease                                          0.00457--0.0142
  Ophthalmic Disease                                                            0.00737--0.0229                                           Respiratory Disease                                          0.00457--0.0142
  Hematological Disease                                                         0.00737--0.0251                                      Renal and Urological Disease                                      0.00532--0.0142
  Inflammatory Disease                                                          0.00749--0.0229                                            Metabolic Disease                                           0.00532--0.0283
  Endocrine System Disorders                                                    0.00761--0.0229                                   Dermatological Diseases & Condition                                  0.00580--0.0283
  Metabolic Disease                                                             0.00761--0.0229                                         Cardiovascular Disease                                         0.00677--0.0142
  Gastrointestinal Disease                                                      0.00761--0.0296                                          Immunological Disease                                         0.00677--0.0283
  Cancer                                                                         0.0114--0.0296                                           Infectious Disease                                           0.00838--0.0265
  Dermatological Diseases & Condition                                            0.0169--0.0229                                            Auditory Disease                                             0.0142--0.0283
  Hepatic System Disease                                                         0.0169--0.0229                                         Developmental Disorder                                          0.0142--0.0283
  Renal and Urological Disease                                                   0.0194--0.0251                                           Ophthalmic Disease                                            0.0142--0.0283
  Auditory Disease                                                                   0.0229                                            Hypersensitivity Response                                            0.0102
  Connective Tissue Disorders                                                        0.0229                                             Antimicrobial Response                                              0.0142
  Neurological Disease                                                               0.0229                                           Reproductive System Disease                                           0.0142
  Nutritional Disease                                                                0.0229                                          Skeletal & Muscular Disorders                                          0.0142
  Skeletal & Muscular Disorders                                                      0.0229                                                                                    

Datasets were analyzed by BioFunction analysis using IPA software.

*P* values were calculated using the right-tailed Fisher exact test and are listed in decreasing order of statistical significance.

Effect of Vaccination with Profilin Plus ISA 71 on Body Weight Gain and Oocyst Shedding {#s3c}
---------------------------------------------------------------------------------------

Because immunization with profilin plus ISA 71 *vs*. profilin alone was associated with more unique biological functions, as well as a larger number of total genes and pathways associated with these functions, compared with profilin/ISA 70 *vs*. profilin alone, we focused on ISA 71 as a possible adjuvant for *in vivo* protection studies against experimental *Eimeria* infection following profilin vaccination. Chickens vaccinated with profilin plus ISA 71 and infected with *E. acervulina* had increased body weight gains between 0 and 10 days post-infection compared with infected chickens vaccinated with profilin alone ([Figure 3](#pone-0059786-g003){ref-type="fig"}). Profilin/ISA 71-vaccinated and *E. maxima*-infected animals had decreased oocyst fecal shedding between days 6 and 10 post-infection compared with infected chickens vaccinated with profilin alone ([Figure 4](#pone-0059786-g004){ref-type="fig"}). Finally, profilin/ISA 71-vaccinated birds that were infected with *E. tenella*- or *E. maxima* had greater anti-profilin serum antibody levels at 3 days post-infection compared with infected birds vaccinated with profilin alone ([Figure 5](#pone-0059786-g005){ref-type="fig"}).

![Effect of vaccination with profilin plus ISA 71 on body weight gain following infection with *E. acervulina, E. tenella*, or *E. maxima*.\
Chickens were subcutaneously vaccinated with PBS, profilin alone, ISA 71 alone, or profilin plus ISA 71 at 7 and 14 days post-hatch. At 7 days post-secondary vaccination, the chickens were uninfected or infected with 1.0×10^4^ sporulated oocysts of *E. acervulina* (E.A), *E. tenella* (E.T), or *E. maxima* (E.M). Body weight gains were measured between 0 and 10 days post-infection. Each bar represents the mean ± S.D. value (n = 8). Within each graph, bars with different letters are significantly different according to the Duncan's multiple range test (*P*\<0.05).](pone.0059786.g003){#pone-0059786-g003}

![Effect of vaccination with profilin plus ISA 71 on fecal oocyst shedding following infection with *E. acervulina, E. tenella*, or *E. maxima*.\
Chickens were vaccinated and infected as described in [Figure 3](#pone-0059786-g003){ref-type="fig"}. Fecal oocyst numbers were measured between 6 and 10 days post-infection. Each bar represents the mean ± S.D. value (n = 8). Within each graph, bars with different letters are significantly different according to the Duncan's multiple range test (*P*\<0.05).](pone.0059786.g004){#pone-0059786-g004}

![Effect of vaccination with profilin plus ISA 71 on serum anti-profilin antibody levels following infection with *E. acervulina, E. tenella*, or *E. maxima*.\
Chickens were vaccinated and infected as described in [Figure 3](#pone-0059786-g003){ref-type="fig"}. Serum anti-profilin antibody levels were measured by ELISA at 3 days post-infection. Each bar represents the mean ± S.D. value (n = 5). Within each graph, bars with different letters are significantly different according to the Duncan's multiple range test (*P*\<0.05).](pone.0059786.g005){#pone-0059786-g005}

Effects of Vaccination with Profilin Plus ISA 71 Adjuvant on Cytokine Transcript Levels in Intestinal IELs {#s3d}
----------------------------------------------------------------------------------------------------------

Chickens vaccinated with profilin plus ISA 71 and infected with all 3 *Eimeria* parasites had greater levels of intestinal IEL gene transcripts encoding IFN-γ, IL-2, IL-10, and/or IL-17A at 3 days post-infection compared with infected birds vaccinated with profilin alone ([Figure 6](#pone-0059786-g006){ref-type="fig"}). The greatest cytokine transcriptional response was seen in the *E. tenella*-infected group. More specifically, *E. tenella*-infected animals had increased levels of all 4 transcripts, while *E. acervulina*-infected birds had greater IL-10 and IL-17A mRNA levels and *E. maxima*-infected birds had increased levels of IFN-γ and IL-17A mRNAs.

![Effect of vaccination with profilin plus ISA 71 on intestinal IEL cytokine transcript levels following infection with *E. acervulina, E. tenella*, or *E. maxima*.\
Chickens were vaccinated and infected as described in [Figure 3](#pone-0059786-g003){ref-type="fig"}. Intestinal IEL transcripts for IFN-γ (A), IL-2 (B), IL-10 (C), and IL-17A (D) were measured by quantitative RT-PCR at 3 days post-infection and normalized to GAPDH transcript levels. Each bar represents the mean ± S.D. value (n = 3). Within each graph, bars with different letters are significantly different according to the Duncan's multiple range test (*P*\<0.05). NS, not significant.](pone.0059786.g006){#pone-0059786-g006}

Discussion {#s4}
==========

This study demonstrated that chickens immunized with profilin plus ISA 70 or profilin plus ISA 71 exhibited spleen lymphocyte transcriptome changes, compared with immunization with profilin alone, that were consistent with alteration of levels of mRNAs encoded by genes belonging to the IPA database category "Disease and Disorder". Compared with profilin/ISA 70 *vs*. profilin alone, the profilin/ISA 71 *vs*. profilin alone comparison was associated with more unique biological functions, and a larger number of genes and pathways associated with these functions, suggesting that vaccination with profilin/ISA 71 may induce a greater protective host response to experimental *Eimeria* infection. Compared with profilin alone, vaccination with profilin/ISA 71 was correlated with (a) increased body weight gains following *E. acervulina* infection, (b) reduced parasite fecal shedding following *E. maxima* infection, (c) augmented anti-profilin serum antibody titers in *E. maxima*- and *E. tenella*-infected chickens, and (d) higher IFN-γ, IL-2, IL-10, and IL-17A transcript levels in gut IELs of *E. acervulina*-, *E. maxima*-, and/or *E. tenella*-infected chickens. Weight gains and parasite shedding were equal in the ISA 71 alone *vs*. PBS negative control groups, and IEL transcript levels were generally equivalent in the ISA 71 only *vs*. profilin alone groups, indicating that the adjuvant itself was not responsible for these effects. Collectively, these data suggest that vaccination of chickens with profilin plus ISA 71 may increase resistance against experimental avian coccidiosis by selective *Eimeria* species.

In general, subunit vaccines against many infectious diseases of livestock and poultry in the absence of adjuvants are weakly immunogenic, and repeated vaccinations are often needed to generate sufficient protective immunity to control infection [@pone.0059786-Belloc1]. While immunologic adjuvants are known to stimulate the host\'s immune system response to a target antigen, without themselves conferring immunity, the limited availability of safe and efficacious adjuvants for veterinary use hampers disease control strategies against some of the more common infectious pathogens of food animals. The Montanide ISA series of adjuvants are ready-to-use W/O, O/W or W/O/W emulsions, incorporating high-grade, injectable mineral or non-mineral oils. Proven benefits in veterinary medicine include the production of stable vaccine emulsions with low viscosity, ease of injection, reduced toxicity, and induction of a strong, long-lasting immune response [@pone.0059786-Aucouturier1], [@pone.0059786-Dupuis1], [@pone.0059786-Aucouturier2], [@pone.0059786-Mata1], [@pone.0059786-Ren1], [@pone.0059786-Toledo1], [@pone.0059786-Waghmare1]. Montanide ISA adjuvants appear to be ideally suited for use with vaccines of limited immunogenicity, such as profilin, an intracellular component that contributes to actin-dependent gliding motility and host cell invasion of apicomplexan parasites, including *Toxoplasma gondii* and *Eimeria* spp. [@pone.0059786-Yarovinsky1]. *T. gondii* profilin binds to Toll-like receptor-11, inducing a potent IL-12 response in dendritic cells, and resulting in enhanced humoral and Th1 cellular immune responses against the parasite [@pone.0059786-Yarovinsky1], [@pone.0059786-Plattner1]. The *E. acervulina* protein, 3-1E, was identified earlier in merozoites of the microorganism as an immunogenic component of the parasite which induced high levels of antigen-specific proliferation and IFN-γ production by chicken splenic lymphocytes [@pone.0059786-Lillehoj1]. Polyclonal antibodies raised against *E. acervulina* 3-1E cross-reacted with the homologous proteins of *E. tenella* and *E. maxima*. Subsequently, 3-1E was shown to be the *Eimeria* homologue of *T. gondii* profilin [@pone.0059786-Yarovinsky1].

We previously reported that compared with unimmunized controls, chickens immunized with profilin in the absence of adjuvant had altered levels of 127 gene transcripts (71 up-regulated, 56 down-regulated). The total number of transcripts affected by profilin/ISA 70 *vs*. profilin alone (509) or profilin/ISA 71 *vs*. profilin alone (296) observed in the current investigation is comparable to the results of our previous studies using other adjuvants and immunomodulators. More specifically, compared with chickens immunized with profilin alone, chickens given profilin plus the Quil A/cholesterol/dimethyl dioctadecyl ammonium bromide/Carbopol (QCDC) adjuvant mixture had 164 altered mRNAs (60 up-regulated, 104 down-regulated), and birds immunized with profilin plus QCDC incorporating the Bay R1005 immunostimulant (QCDCR) had 233 modulated transcripts (103 up-regulated, 130 down-regulated) [@pone.0059786-Kim4]. In a subsequent study in the absence of profilin vaccination, dietary supplementation of chickens with propyl thiosulfinate, a secondary metabolite of garlic with immunoenhancing properties, identified 1,227 transcripts whose levels were altered in intestinal IELs compared with untreated controls [@pone.0059786-Kim3]. As in the current report, biological pathway analysis identified the propyl thiosulfinate-altered transcripts to be encoded by genes associated with the IPA category "Disease and Disorder".

Interestingly, whereas ISA 70 and ISA 71 are composed of similar adjuvant formulations, only 22 common transcripts were shared between the profilin/ISA 70 *vs*. profilin alone and the profilin/ISA 71 *vs*. profilin alone groups, representing 4.3% and 7.4% of the total number of altered mRNAs, respectively. On the other hand, comparison of profilin/ISA 70-immunized chickens with the profilin/ISA 71 group identified 315 altered transcripts, indicating that the number of dissimilar mRNAs was substantially greater than the number of shared transcripts. Correspondingly, a similar comparison using the QCDC and QCDCR adjuvants revealed 397 altered transcripts in the profilin/QCDC *vs*. profilin/QCDCR groups [@pone.0059786-Kim4]. In another study, comparative microarray analysis between uninfected *vs*. *E. acervulina*, *E. tenella*, or *E. maxima* infections was used to identify commonly altered transcripts in these 3 denoted groups [@pone.0059786-Kim2]. Following *E. acervulina* infection, 2,431 mRNAs were altered, while infection with *E. tenella* and *E. maxima* modulated the levels of 2,522 and 1,717 mRNAs respectively. From these, 766 transcripts were common to *E. acervulina* and *E. tenella*, 319 were shared between *E. acervulina* and *E. maxima*, 289 were common to *E. tenella* and *E. maxima*, and 361 mRNAs were shared between all 3 infections. Taken together, these results indicate that infection with intact, viable coccidia parasites stimulates a greater host transcriptional response compared with profilin vaccination in the presence or absence of adjuvant.

Body weight gain and fecal oocyst shedding are reliable clinical signs for the evaluation of protective immunity in avian coccidiosis [@pone.0059786-Lee1]. Both parameters are directly correlated with the levels of intestinal proinflammatory cytokines in *Eimeria*-infected chickens [@pone.0059786-Lillehoj2], [@pone.0059786-Hong3], [@pone.0059786-Hong4]. IFN-γ plays a critical role in the *Eimeria*-stimulated host immune response, and is one of the earliest cytokines detected in infected intestinal mucosa [@pone.0059786-Lillehoj3]. Indeed, IFN-γ is the dominant cytokine elicited in the gut of *Eimeria*-infected chickens that typifies the Th1 cell-mediated immune response seen during experimental avian coccidiosis [@pone.0059786-Yun1]. Endogenous IFN-γ production in gut epithelia was positively associated with improved body weight gain and decreased oocyst shedding in birds following *Eimeria* infection [@pone.0059786-Lillehoj2]. Chickens treated exogenously with puified recombinant IFN-γ protein showed greater weight gain and reduced fecal oocyst numbers following *E. acervulina* infection [@pone.0059786-Lillehoj4]. IL-2 and IL-17A are other members of this Th1 cytokine response that serve to recruit, activate, and amplify immune effector leukocytes with cytotoxic activtiy against coccidia parasites [@pone.0059786-Lillehoj5], [@pone.0059786-Lillehoj6]. On the other hand, IL-10 driven inhibition of IFN-γ production suggests that this counter-regulatory mediator may favor a shift toward a Th2 response later in the course of infection, and prevent tissue damage as a consequence of uncontrolled intestinal inflammation [@pone.0059786-Rothwell1]. Therefore, augmented production of IFN-γ, IL-2, IL-17A, and IL-10 by profilin plus ISA 71 appears to preserve the natural balance of pro- and anti-inflammatory pathways in the gut that are necessary for an effective cellular immune response against the invading parasite while maintaining tissue homeostasis.

In conclusion, this study identified transcriptome dynamics in chickens following immunization with the *Eimeria* recombinant profilin protein in combination with either the ISA 70 or ISA 71 W/O adjuvants by comparison with immunization with profilin alone. Based on the greater transcriptional response elicited by profilin/ISA 71, this antigen/adjuvant mixture was used to subsequently demonstrate increased protection against experimental avian coccidiosis, as assessed by augmented body weight gains, decreased parasite fecal shedding, greater anti-profilin serum antibody titers, and increased levels of cytokine gene transcripts compared with vaccination with profilin alone. These results suggest that profilin in conjunction with ISA 71 provides an effective means of eliciting humoral and cellular immune responses with the potential to generate protective immunity against *Eimeria* infection.
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